Marriage associated with better cancer outcomes, study finds

September 23, 2013

People who are married when diagnosed with cancer live longer than those who are not, report researchers at Dana-Farber Cancer Institute and Brigham and Women's Hospital. Married patients also tended to have cancers diagnosed at an earlier stage – when it is often more successfully treated – and to receive more appropriate treatment.

The study's findings will be published online by the Journal of Clinical Oncology on Sept. 23.

"Our data suggests that marriage can have a significant health impact for patients with , and this was consistent among every cancer that we reviewed," said Ayal Aizer, MD MHS, chief resident of the Harvard Radiation Oncology Program and the paper's first author. "We suspect that social support from spouses is what's driving the striking improvement in survival. Spouses often accompany patients on their visits and make sure they understand the recommendations and complete all their treatments."

Utilizing the National Cancer Institute's Surveillance, Epidemiology and End Results Program, the researchers conducted a retrospective analysis of 734,889 people who were diagnosed with cancer between 2004 and 2008. They focused on the 10 leading causes of cancer deaths in the United States: lung, colorectal, breast, pancreatic, prostate, liver/bile duct, non-Hodgkin lymphoma, head and neck, ovarian, and esophageal cancer. They also adjusted the data to account for a number of , including age, sex, race, residence type, education and median household income, that could have an effect on the health outcome.

Their analysis found that in comparison with married patients, unmarried , including those who were widowed, were 17 percent more likely to have metastatic cancer (cancer that spread beyond its original site) and were 53 percent less likely to receive the appropriate therapy.

"We don't just see our study as an affirmation of marriage, but rather it should send a message to anyone who has a friend or a loved one with cancer: by being there for that person and helping them navigate their appointments and make it through all their treatments, you can make a real difference to that person's outcome," said the study's senior author Paul Nguyen, MD, a radiation oncologist at Dana-Farber and Brigham and Women's. "As oncologists, we need to be aware of our patients' available social supports and encourage them to seek and accept support from friends and family during this potentially difficult time."

Explore further: Study links Hodgkin lymphoma treatment to possible risk of stomach cancer

Related Stories

Study links Hodgkin lymphoma treatment to possible risk of stomach cancer

August 27, 2013
(Medical Xpress)—Hodgkin lymphoma survivors who received certain radiation and chemotherapy regimens were at increased risk of subsequently developing stomach cancer, according to a study by scientists at the National Cancer ...

Married lung cancer patients survive longer than single patients after treatment

September 6, 2012
Married patients with locally advanced lung cancer are likely to survive longer after treatment than patients who are single, according to a study by researchers at the University of Maryland Marlene and Stewart Greenebaum ...

Marital status, race increase survival rate significantly for Stage III non-small cell lung cancer patients

September 6, 2012
A study of survival data for Stage III, non-small cell lung cancer (NSCLC) patients at the University of Maryland's Greenebaum Cancer Center in Baltimore indicates that marital status and race can significantly impact patient ...

Major cancer genotyping study logs 5,000th tumor profile

September 12, 2013
More than 5,000 genetic profiles of tumor DNA have been completed in a large research study by scientists at Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Boston Children's Hospital designed to speed the ...

In nonsmoking women, breastfeeding for more than six months may protect against breast cancer

August 15, 2013
A new analysis has found that breastfeeding for more than six months may safeguard nonsmoking mothers against breast cancer. The same does not seem to hold true for smoking mothers, though. Published early online in the Journal ...

Study finds genomic differences in types of cervical cancer

August 23, 2013
A new study has revealed marked differences in the genomic terrain of the two most common types of cervical cancer, suggesting that patients might benefit from therapies geared to each type's molecular idiosyncrasies.

Recommended for you

Study may explain failure of retinoic acid trials against breast cancer

July 25, 2017
Estrogen-positive breast cancers are often treated with anti-estrogen therapies. But about half of these cancers contain a subpopulation of cells marked by the protein cytokeratin 5 (CK5), which resists treatment—and breast ...

Physical activity could combat fatigue, cognitive decline in cancer survivors

July 25, 2017
A new study indicates that cancer patients and survivors have a ready weapon against fatigue and "chemo brain": a brisk walk.

Breaking the genetic resistance of lung cancer and melanoma

July 25, 2017
Researchers from Monash University and the Memorial Sloan Kettering Cancer Center (MSKCC, New York) have discovered why some cancers – particularly lung cancer and melanoma – are able to quickly develop deadly resistance ...

New therapeutic approach for difficult-to-treat subtype of ovarian cancer identified

July 24, 2017
A potential new therapeutic strategy for a difficult-to-treat form of ovarian cancer has been discovered by Wistar scientists. The findings were published online in Nature Cell Biology.

Immune cells the missing ingredient in new bladder cancer treatment

July 24, 2017
New research offers a possible explanation for why a new type of cancer treatment hasn't been working as expected against bladder cancer.

Anti-cancer chemotherapeutic agent inhibits glioblastoma growth and radiation resistance

July 24, 2017
Glioblastoma is a primary brain tumor with dismal survival rates, even after treatment with surgery, chemotherapy and radiation. A small subpopulation of tumor cells—glioma stem cells—is responsible for glioblastoma's ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.